Debin Sun
Wuxi, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Efficacy of continuing pembrolizumab after progression on first-line treatment in stage IV non-small cell lung cancer: a prospective real-world study.
Journal: American journal of cancer research
Published: September 01, 2025
Chromosome 11q13 amplification as a decision-making biomarker for anti-PD-1 immunotherapy in recurrent or metastatic head and neck squamous cell carcinoma: a prospective cohort study.
Journal: Frontiers in immunology
Published: July 17, 2025
The effective molecular characteristics of PD-1 inhibitor combination regimen as the first-line treatment for Chinese patients with HER2-positive gastric cancer: a real-world retrospective analysis study.
Journal: Translational gastroenterology and hepatology
Published: July 21, 2024
Lymph node metastasis in early invasive lung adenocarcinoma: Prediction model establishment and validation based on genomic profiling and clinicopathologic characteristics.
Journal: Cancer medicine
Published: January 06, 2024
Immune microenvironment heterogeneity of concurrent adenocarcinoma and squamous cell carcinoma in multiple primary lung cancers.
Journal: NPJ precision oncology
Published: June 17, 2023
Chronic obstructive pulmonary disease alters the genetic landscape and tumor immune microenvironment in lung cancer patients.
Journal: Frontiers in oncology
Published: February 21, 2023
Pralsetinib treatment for multiple RET fusions in lung adenocarcinoma: a case report.
Journal: The Journal of international medical research
Published: June 25, 2022
Molecular evolutionary process of advanced gastric cancer during sequential chemotherapy detected by circulating tumor DNA.
Journal: Journal of translational medicine
Published: May 09, 2022
Immune-related lncRNA signature delineates an immune-excluded subtype of liver cancer with unfavorable clinical outcomes.
Journal: Journal of clinical laboratory analysis
Published: November 25, 2021
EGFR Mutation and 11q13 Amplification Are Potential Predictive Biomarkers for Immunotherapy in Head and Neck Squamous Cell Carcinoma.
Journal: Frontiers in immunology
Published: November 12, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026